Vivre avec le VIH en France en 2011
HIV Grand Round F2 Dr Sris Allan Consultant GU / HIV Physician Honorary Associate Professor.
GUIDELINES FOR IMPROVING ENTRY INTO AND RETENTION IN CARE AND ANTIRETROVIRAL ADHERENCE FOR PERSONS WITH HIV Developed by a Panel Convened by the International.
MINNESOTAS HIV TREATMENT CASCADE. Introduction This slide set describes the continuum of HIV care in Minnesota. The slides rely on data from HIV/AIDS.
HIV incidence determination in clade B epidemics: A multi-assay approach Oliver Laeyendecker, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell.
Antiretroviral Therapy: An HIV Prevention Strategy? Wafaa El-Sadr, MD, MPH Columbia University Harlem Hospital New York.
Impact of Tryptophan Catabolism on CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating ART Peter W. Hunt, Sheri Weiser, Yong Huang,
HIV and Aging: a Time for a New Paradigm Amy C. Justice, MD, MSCE, PhD Professor, Yale University Section Chief, General Internal Medicine VA Connecticut.
The San Francisco HIV Prevention Strategy, 2012-2016: An Integrated, Citywide Approach HIV Prevention Planning Council November 8, 2012.
HPTN Test and Treat (TNT) Design Issues and Implications for a Domestic Research Agenda Sten Vermund, Wafaa El-Sadr, Kenneth Mayer on behalf of the HPTN.
Switching HIV Regimens – When, Why, and to What Pedro Cahn, MD Frank Palella, MD Graeme Moyle, MD Calvin Cohen, MD.
Organizing Clinical research Pr Christine Katlama Hopital pitié salpetriere Université pierre et marie Curie ECRECO AIX Sept 2013.